Obesity, insulin resistance, and cardiovascular disease

Recent Progress in Hormone Research

Volumn 59, Issue , 2004, Pages 207-223

  Reaven, Gerald ^a   Abbasi, Fahim ^a   McLaughlin, Tracey ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INSULIN;

BODY MASS; CALORIC INTAKE; CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; DYSLIPIDEMIA; ENERGY EXPENDITURE; FATTY LIVER; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; REVIEW; STROKE; WEIGHT REDUCTION; ANIMAL; BLOOD; RISK FACTOR;

ANIMALS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; OBESITY; RISK FACTORS; WEIGHT LOSS;

EID: 2342430250     PISSN: 00799963     EISSN: None     Source Type: Journal    
DOI: 10.1210/rp.59.1.207     Document Type: Review

References (27)

1. Abbasi F, McLaughlin T, Lamendola C, Lipinska I, Tofler G, Reaven GM 1999 Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women. Arterioscler Thromb Vasc Biol 19:2818-2821
2. Abbasi F, Brown BWB, Lamendola C, McLaughlin T, Reaven GM 2002 Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40:937-994
3. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven GM 1985 Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248(Endocr Metab 11):E286-E291
4. Facchini FS, Hua N, Abbasi F, Reaven GM 2001 Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86:3574-3578
5. Galuska DA, Will JC, Serdula MK, Ford ES 1999 Are health care professionals advising obese patients to lose weight? JAMA 282:1576-1578
6. Greenfield MS, Doberne L, Kraemer FB, Tobey TA, Reaven GM 1981 Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30:387-392
7. Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M 1983 Weight and hypertension. Ann Intern Med 98:855-854
8. Hollenbeck CB, Chen YD-I, Reaven GM 1984 A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization. Diabetes 33:622-626
9. Karam JH, Pavlatos FC, Grodsky GM, Forsham PH 1965 Critical factors in excessive serum-insulin response to glucose. Lancet 1:286-289
10. Khan LK, Serdula MK, Bowman BA, Williamson DF 2001 Use of prescription weight loss pills among US adults in 1996-1998. Ann Intern Med 134:282-286
11. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP 1997 Varying body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1988 to 1994). Obesity Res 5:542-548
12. McLaughlin T, Abbasi F, Carantoni M, Schaaf P, Reaven GM 1999 Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. J Clin Endocrinol Metab 84:578-581
13. McLaughlin T, Abbasi F, Kim, H-S, Lamendola C, Schaaf P, Reaven GM 2001 Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 50:795-800
14. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, Reaven P 2002 Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106:2908-2912
15. Olefsky JM, Reaven GM, Farquhar JW 1974 Effects of weight reduction on obesity: studies of carbohydrate and lipid metabolism. J Clin Invest 53:64-76
16. Pei D, Jones CNO, Bhargava R, Chen YD-I, Reaven GM 1994 Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37:843-845
17. Rabinowitz D, Zierler KJ 1962 Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinemia. J Clin Invest 41:2173-2181
18. Reaven GM 1988 Role of insulin resistance in human disease. Diabetes 37:1595-1607
19. Reaven GM 2001 Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease: syndrome X revisited. In: Jefferson LS, Cherrington AD, eds. Handbook of Physiology, vol II, section 7. Oxford, UK: Oxford University Press; 1169-1197
20. Reaven GM, Miller R 1968 Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 17:560-569
21. Reaven GM, Chen YD-I, Hollenbeck CB, Sheu WW-H, Ostrega D, Polonsky KS 1993 Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 76:44-48
22. Rimm EB, Stampfer MJ, Giovannucci E, et al. 1995 Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 141:1117-1127
23. Shen S-W, Reaven GM, Farquhar JW 1970 Comparison of impedance to insulin mediated glucose uptake in normal and diabetic subjects. J Clin Invest 49:2151-2160
24. West KM, Kalbfleisch JM 1971 Influence of nutritional factors on prevalence of diabetes. Diabetes 20:99-108
25. Yalow RS, Berson SA 1960 Immunoassay of endogenous insulin in man. J Clin Invest 39:1157-1175
26. Yip J, Facchini FS, Reaven GM 1998 Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83:2773-2776
27. Zavaroni I, Bonini L, Gasparini P, Barilli AL, Zuccarelli A, Dall'Aglio E, et al. 1999 Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism 48:989-994